84 related articles for article (PubMed ID: 17382534)
1. Loss of imprinting of insulin-like growth factor II is associated with increased risk of proximal colon cancer.
Liou JM; Wu MS; Lin JT; Wang HP; Huang SP; Chiu HM; Lee YC; Lin YB; Shun CT; Liang JT
Eur J Cancer; 2007 May; 43(8):1276-82. PubMed ID: 17382534
[TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.
Cui H; Horon IL; Ohlsson R; Hamilton SR; Feinberg AP
Nat Med; 1998 Nov; 4(11):1276-80. PubMed ID: 9809551
[TBL] [Abstract][Full Text] [Related]
3. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
4. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
Gallagher EM; O'Shea DM; Fitzpatrick P; Harrison M; Gilmartin B; Watson JA; Clarke T; Leonard MO; McGoldrick A; Meehan M; Watson C; Furlong F; O'Kelly P; Fitzpatrick JM; Dervan PA; O'Grady A; Kay EW; McCann A
Clin Cancer Res; 2008 Nov; 14(21):6829-38. PubMed ID: 18980977
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort.
Kaaks R; Stattin P; Villar S; Poetsch AR; Dossus L; Nieters A; Riboli E; Palmqvist R; Hallmans G; Plass C; Friesen MD
Cancer Res; 2009 Jul; 69(13):5400-5. PubMed ID: 19549920
[TBL] [Abstract][Full Text] [Related]
7. Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma.
Hattori H; Matsuzaki A; Suminoe A; Ihara K; Eguchi M; Tajiri T; Suita S; Ishii E; Hara T
Cancer; 2000 May; 88(10):2372-7. PubMed ID: 10820361
[TBL] [Abstract][Full Text] [Related]
8. Genomic imprinting of insulin-like growth factor 2 (IGF-2) in chronic synovitis.
Möller B; Kerschbaumer G; Komor M; Kerschbaumer F; Ottmann OG; Hoelzer D; Hofmann WK
Growth Horm IGF Res; 2007 Dec; 17(6):500-5. PubMed ID: 17590364
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T
Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831
[TBL] [Abstract][Full Text] [Related]
10. [Loss of imprinting of insulin-like growth factor II gene in acute myeloid leukemia].
Liu Y; Yang B; Zhu H; Wang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):39-41. PubMed ID: 10653908
[TBL] [Abstract][Full Text] [Related]
11. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.
Cui H; Cruz-Correa M; Giardiello FM; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Powe NR; Feinberg AP
Science; 2003 Mar; 299(5613):1753-5. PubMed ID: 12637750
[TBL] [Abstract][Full Text] [Related]
12. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
13. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
Xu W; Fan H; He X; Zhang J; Xie W
J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
[TBL] [Abstract][Full Text] [Related]
15. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer.
Liou JM; Shun CT; Liang JT; Chiu HM; Chen MJ; Chen CC; Wang HP; Wu MS; Lin JT
J Clin Endocrinol Metab; 2010 Apr; 95(4):1717-25. PubMed ID: 20157191
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of IGF-II gene imprinting in twin placentas].
Luo YM; Fang Q; Zhuang GL; Liang RC; Liu QL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):497-501. PubMed ID: 17029194
[TBL] [Abstract][Full Text] [Related]
18. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
Cacev T; Radosević S; Krizanac S; Kapitanović S
Carcinogenesis; 2008 Aug; 29(8):1572-80. PubMed ID: 18628251
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin-like growth factor-1 in colon cancerogenesis: a case-control study.
Tripkovic I; Tripkovic A; Strnad M; Capkun V; Zekan L
Arch Med Res; 2007 Jul; 38(5):519-25. PubMed ID: 17560457
[TBL] [Abstract][Full Text] [Related]
20. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
